ArticleNature communications2022

Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro.

Leiping Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.